IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
PIPPHARMACON & IJPR 2018

PIPPHARMACON & IJPR 2018

Click to download
 

Article Detail

Label
Label
Features of Cellularand Humoral Immunore activity in Patients with Stable Angina and their Role in the Progression of Athrosclerotic Lesions

Author: VASILENKO V.S., AVDEEVA M.V., SHCHEGLOVA L.V, SHCHEGLOV D.S
Abstract: The purpose of the research was to examine the relationship between cellular and humoral immunoreactivity and the severity of atherosclerotic lesions of coronary arteries in patients with stable angina. We examined 68 patients with stable angina (mean age 60.2±10.3 years). The patients underwent coronary angiography in addition to numbers of immunological studies including the determination of the levels of circulating immune complexes, the leukocyte migration-inhibitory index (LMI) in presence of various antigens, the concentration of myocardial antigens in the blood as well as antibodies to them. We established a direct correlation between the level of circulating immune complexes and the development of hemodynamically significant coronary stenosis (r=0.32; p<0.05), as well as their amount (r=0.28; p<0.05) and the length of stenosis (r=0.32; p<0.05). We also found a correlation between the level of circulating immune complexes and the degree of stenosis of particular segments of coronary arteries (r=0.36?0.26; p<0.05). The titer of myocardial antigens associated with the total number of coronary occlusions (r=0.51; p<0.05), the number of hemodynamically significant stenosis (r=0.58; p<0.05) and the degree of coronary stenosis (r=0.57?0.46; p<0.05). The number of occlusions of the lumen of coronary arteries statistically significantly associated with the leukocyte migration-inhibitory index (LMI) stimulated by phytohemagglutinin(r=0.41; p<0.05). The study showed that cellular and humoral immunoreactivity are involved in the pathogenetic mechanisms of progression of atherosclerotic lesions of the coronary arteries. This should be considered when developing new technologies for treating cardiovascular diseases.
Keyword: atherosclerosis, humoral and cellular immunoreactivity, cardiovascular disease, coronary heart disease, multifocal atherosclerosis.
DOI: https://doi.org/10.31838/ijpr/2019.11.01.078
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
AICTE INTERNATIONAL CONFERENCE

AICTE Sponsored International Conference on Challenges, Opportunities and Newer Directions of Pharmacovigilance and Clinical Research in India

Download Brochure


For More Detail Visit www.pippharmacon.org
News & Events
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477